Victory Capital Management
AGTC

Victory Capital Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Victory Capital Management’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,713
Closed -$12K – 3533
2020
Q1 		$12K Buy
+3,713
New +$19.6K ﹤0.01% 3031
2019
Q4 		– Sell
-2,015
Closed -$8K – 3518
2019
Q3 		$8K Buy
+2,015
New +$7.28K ﹤0.01% 3350

Other funds holding AGTC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
Sofinnova Investments
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Portolan Capital Management
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

Victory Capital Management's AGTC Position: Q2 2020 in Review

Victory Capital Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2020, closing a stake of 3,713 shares — an estimated $12K sold.

Victory Capital Management first reported a position in AGTC in Q3 2019 and held it in 2 quarters. The position peaked at $12K in Q1 2020. 65 funds tracked by Wall St. Rank hold AGTC as of Q2 2020.

  • Victory Capital Management reported no remaining Applied Genetic Technologies Corporation position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 3,713 Applied Genetic Technologies Corporation shares in Q2 2020, an estimated $12K.
  • Victory Capital Management first reported a position in Applied Genetic Technologies Corporation in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Applied Genetic Technologies Corporation position peaked at $12K in Q1 2020.
  • 65 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.